JPWO2022070798A1 - - Google Patents

Info

Publication number
JPWO2022070798A1
JPWO2022070798A1 JP2022553732A JP2022553732A JPWO2022070798A1 JP WO2022070798 A1 JPWO2022070798 A1 JP WO2022070798A1 JP 2022553732 A JP2022553732 A JP 2022553732A JP 2022553732 A JP2022553732 A JP 2022553732A JP WO2022070798 A1 JPWO2022070798 A1 JP WO2022070798A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022553732A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022070798A1 publication Critical patent/JPWO2022070798A1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2022553732A 2020-09-29 2021-09-07 Pending JPWO2022070798A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020163105 2020-09-29
PCT/JP2021/032787 WO2022070798A1 (ja) 2020-09-29 2021-09-07 アルツハイマー病病態鑑別用組み合わせマーカー及びそれを用いたアルツハイマー病病態鑑別方法

Publications (1)

Publication Number Publication Date
JPWO2022070798A1 true JPWO2022070798A1 (https=) 2022-04-07

Family

ID=80950150

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022553732A Pending JPWO2022070798A1 (https=) 2020-09-29 2021-09-07

Country Status (2)

Country Link
JP (1) JPWO2022070798A1 (https=)
WO (1) WO2022070798A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4632384A1 (en) * 2022-12-05 2025-10-15 AlzMed, Inc. Method for determining cognitive dysfunction stage

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007524847A (ja) * 2003-11-07 2007-08-30 サイファージェン バイオシステムズ インコーポレイテッド アルツハイマー病のためのバイオマーカー
WO2008029886A1 (en) * 2006-09-06 2008-03-13 National University Corporation Tottori University Kit for diagnosis of alzheimer's disease, diagnostic marker, and method for detection of indicator for disease condition
US20140357525A1 (en) * 2013-03-26 2014-12-04 Duke University Markers for alzheimer's disease and mild cognitive impairment and methods of using the same
JP2015004664A (ja) * 2013-06-18 2015-01-08 磁量生技股▲ふん▼有限公司 アルツハイマー病罹患リスクを検出する方法
WO2017195778A1 (ja) * 2016-05-10 2017-11-16 橋本 康弘 認知症の診断マーカー及びそれを用いた認知症罹患鑑別方法
WO2019022064A1 (ja) * 2017-07-25 2019-01-31 長谷川 亨 神経変性疾患を判定するための診断補助方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007524847A (ja) * 2003-11-07 2007-08-30 サイファージェン バイオシステムズ インコーポレイテッド アルツハイマー病のためのバイオマーカー
WO2008029886A1 (en) * 2006-09-06 2008-03-13 National University Corporation Tottori University Kit for diagnosis of alzheimer's disease, diagnostic marker, and method for detection of indicator for disease condition
US20140357525A1 (en) * 2013-03-26 2014-12-04 Duke University Markers for alzheimer's disease and mild cognitive impairment and methods of using the same
JP2015004664A (ja) * 2013-06-18 2015-01-08 磁量生技股▲ふん▼有限公司 アルツハイマー病罹患リスクを検出する方法
WO2017195778A1 (ja) * 2016-05-10 2017-11-16 橋本 康弘 認知症の診断マーカー及びそれを用いた認知症罹患鑑別方法
WO2019022064A1 (ja) * 2017-07-25 2019-01-31 長谷川 亨 神経変性疾患を判定するための診断補助方法

Also Published As

Publication number Publication date
WO2022070798A1 (ja) 2022-04-07

Similar Documents

Publication Publication Date Title
CN306007656S (https=)
CN305533558S (https=)
CN305579037S (https=)
CN305612063S (https=)
CN305613059S (https=)
CN305620112S (https=)
CN305621636S (https=)
CN305627565S (https=)
CN305647473S (https=)
CN305649575S (https=)
CN305676678S (https=)
CN305682608S (https=)
CN305683292S (https=)
CN305683800S (https=)
CN305703379S (https=)
CN305707430S (https=)
CN305718831S (https=)
CN305722016S (https=)
CN305722218S (https=)
CN305792551S (https=)
CN306004931S (https=)
CN305810236S (https=)
CN305813251S (https=)
CN305813738S (https=)
CN305818845S (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230316

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240716